MWA
ABBV icon

Medallion Wealth Advisors’s AbbVie ABBV Stock Holding History

Medallion Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$472K Sell
1,877
-669
-26% -$144K 0.15% 131
2026
Q1 		$554K Sell
2,546
-87
-3% -$19.3K 0.18% 116
2025
Q4 		$602K Sell
2,633
-77
-3% -$17.5K 0.2% 109
2025
Q3 		$627K Sell
2,710
-3
-0.1% -$611 0.22% 108
2025
Q2 		$513K Sell
2,713
-92
-3% -$17.1K 0.2% 117
2025
Q1 		$581K Buy
2,805
+520
+23% +$101K 0.26% 92
2024
Q4 		$427K Buy
+2,285
New +$420K 0.21% 107

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Medallion Wealth Advisors's ABBV Position: Q2 2026 in Review

Medallion Wealth Advisors reduced its AbbVie (ABBV) stake by 26% in Q2 2026, selling an estimated $144K and leaving 1,877 shares worth $472K. The position accounts for 0.15% of the portfolio, ranked #131.

Medallion Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $627K in Q3 2025. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Medallion Wealth Advisors held 1,877 shares of AbbVie worth $472K as of Q2 2026.
  • Medallion Wealth Advisors sold 669 AbbVie shares in Q2 2026, an estimated $144K.
  • AbbVie made up 0.15% of Medallion Wealth Advisors's portfolio in Q2 2026, its #131 holding.
  • Medallion Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Medallion Wealth Advisors's AbbVie position peaked at $627K in Q3 2025.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Medallion Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.